Doxorubicin Active Not Recruiting Phase 1 Trials for Neoplasms Treatment

IndicationsStatusPurposePhase
Active Not RecruitingTreatment1
clinicaltrials.gov IdentifierTitleDrugs
NCT02377752A Study of Olaratumab in Japanese Participants With Advanced Cancer